3PBIOVIAN Achieves French CIR Certification for Finland, Spain Sites

3PBIOVIAN has successfully obtained French Crédit d’Impôt Recherche (CIR) certification for its facilities in Turku, Finland, and Pamplona, Spain, which will remain valid until 2027. This certification allows French partners to benefit from significant R&D tax incentives when collaborating with 3PBIOVIAN on eligible projects, enhancing the company’s capacity to support international research initiatives.

The CIR certification recognises the eligibility of the services offered by 3PBIOVIAN for research and development activities undertaken by French companies. This designation provides a framework that encourages partnerships focused on innovation and technological advancement in the biotechnology sector.

Significance of Certification

The newly acquired CIR certification marks a significant milestone for the Turku site, which has achieved this designation for the first time. Meanwhile, the Pamplona site has successfully completed its recertification process, as it had previously held this honour. With both locations now secured under the CIR certification, 3PBIOVIAN strengthens its position as a leader in delivering comprehensive solutions for the development and contract manufacturing of recombinant proteins and advanced therapies.

In a statement regarding this achievement, the company emphasised its commitment to providing high-value R&D services and fostering international collaboration. This certification is set to enhance operational excellence for its clients, ultimately contributing to advancements in biotechnological innovations that benefit patients.

3PBIOVIAN’s ability to deliver end-to-end solutions is further bolstered by this certification, as it aligns with the company’s strategy to support scientific and technological projects that drive progress within the industry. The implications of this certification are expected to resonate throughout the biotechnology community, encouraging further investment in research and development initiatives.

Through this accomplishment, 3PBIOVIAN not only enhances its service offerings but also positions itself as a valuable partner for French firms seeking to leverage R&D tax incentives. The certification highlights the company’s ongoing dedication to innovation and collaboration, setting a robust foundation for future partnerships in the rapidly evolving biotechnology landscape.